These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27784797)

  • 1. YopJ Family Effectors Promote Bacterial Infection through a Unique Acetyltransferase Activity.
    Ma KW; Ma W
    Microbiol Mol Biol Rev; 2016 Dec; 80(4):1011-1027. PubMed ID: 27784797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two serine residues in Pseudomonas syringae effector HopZ1a are required for acetyltransferase activity and association with the host co-factor.
    Ma KW; Jiang S; Hawara E; Lee D; Pan S; Coaker G; Song J; Ma W
    New Phytol; 2015 Dec; 208(4):1157-68. PubMed ID: 26103463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disabling surveillance: bacterial type III secretion system effectors that suppress innate immunity.
    Espinosa A; Alfano JR
    Cell Microbiol; 2004 Nov; 6(11):1027-40. PubMed ID: 15469432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of a pathogen effector reveals the enzymatic mechanism of a novel acetyltransferase family.
    Zhang ZM; Ma KW; Yuan S; Luo Y; Jiang S; Hawara E; Pan S; Ma W; Song J
    Nat Struct Mol Biol; 2016 Sep; 23(9):847-52. PubMed ID: 27525589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The YopJ superfamily in plant-associated bacteria.
    Lewis JD; Lee A; Ma W; Zhou H; Guttman DS; Desveaux D
    Mol Plant Pathol; 2011 Dec; 12(9):928-37. PubMed ID: 21726386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acetyltransferase activity of the bacterial toxin YopJ of Yersinia is activated by eukaryotic host cell inositol hexakisphosphate.
    Mittal R; Peak-Chew SY; Sade RS; Vallis Y; McMahon HT
    J Biol Chem; 2010 Jun; 285(26):19927-34. PubMed ID: 20430892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity and Evolution of Type III Secreted Effectors: A Case Study of Three Families.
    Bastedo DP; Lo T; Laflamme B; Desveaux D; Guttman DS
    Curr Top Microbiol Immunol; 2020; 427():201-230. PubMed ID: 31240408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of host substrate acetylation by a YopJ family effector.
    Zhang ZM; Ma KW; Gao L; Hu Z; Schwizer S; Ma W; Song J
    Nat Plants; 2017 Jul; 3():17115. PubMed ID: 28737762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation of YopJ family effector proteins through the VirB/VirD4 T4SS of
    Fromm K; Ortelli M; Boegli A; Dehio C
    Proc Natl Acad Sci U S A; 2024 May; 121(20):e2310348121. PubMed ID: 38709922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation.
    Mukherjee S; Keitany G; Li Y; Wang Y; Ball HL; Goldsmith EJ; Orth K
    Science; 2006 May; 312(5777):1211-4. PubMed ID: 16728640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease.
    Orth K; Xu Z; Mudgett MB; Bao ZQ; Palmer LE; Bliska JB; Mangel WF; Staskawicz B; Dixon JE
    Science; 2000 Nov; 290(5496):1594-7. PubMed ID: 11090361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type III secretion systems and disease.
    Coburn B; Sekirov I; Finlay BB
    Clin Microbiol Rev; 2007 Oct; 20(4):535-49. PubMed ID: 17934073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Xanthomonas AvrXv4 effector, a SUMO protease translocated into plant cells.
    Roden J; Eardley L; Hotson A; Cao Y; Mudgett MB
    Mol Plant Microbe Interact; 2004 Jun; 17(6):633-43. PubMed ID: 15195946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behind the lines-actions of bacterial type III effector proteins in plant cells.
    Büttner D
    FEMS Microbiol Rev; 2016 Nov; 40(6):894-937. PubMed ID: 28201715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subterfuge and manipulation: type III effector proteins of phytopathogenic bacteria.
    Grant SR; Fisher EJ; Chang JH; Mole BM; Dangl JL
    Annu Rev Microbiol; 2006; 60():425-49. PubMed ID: 16753033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to Type III Secretion Systems.
    Condry DL; Nilles ML
    Methods Mol Biol; 2017; 1531():1-10. PubMed ID: 27837477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type III secretion machines: bacterial devices for protein delivery into host cells.
    Galán JE; Collmer A
    Science; 1999 May; 284(5418):1322-8. PubMed ID: 10334981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling.
    Paquette N; Conlon J; Sweet C; Rus F; Wilson L; Pereira A; Rosadini CV; Goutagny N; Weber AN; Lane WS; Shaffer SA; Maniatis S; Fitzgerald KA; Stuart L; Silverman N
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12710-5. PubMed ID: 22802624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial Type IV secretion systems: versatile virulence machines.
    Voth DE; Broederdorf LJ; Graham JG
    Future Microbiol; 2012 Feb; 7(2):241-57. PubMed ID: 22324993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Xanthomonas campestris type III effector XopJ proteolytically degrades proteasome subunit RPT6.
    Üstün S; Börnke F
    Plant Physiol; 2015 May; 168(1):107-19. PubMed ID: 25739698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.